Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kröger, N.
Right arrow Articles by Zander, A.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kröger, N.
Right arrow Articles by Zander, A.R.
Stem Cells, Vol. 16, No. 1, 49-53, January 1998
© 1998 AlphaMed Press

Difference between Expression of Adhesion Molecules on CD34+ Cells from Bone Marrow and G-CSF-Stimulated Peripheral Blood

N. Krögera, W. Zellera, H.T. Hassana, J. Dierlammb, A.R. Zandera

a Bone Marrow Transplantation Unit,
b Department of Oncology and Hematology, University Hospital Hamburg, Hamburg, Germany

Key Words. Adhesion molecules • Mobilization of CD34+ cells • Bone marrow

Dr. Nicolaus Kröger, Bone Marrow Transplantation Unit, Department of Oncology and Hematology, University Hospital Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany.

Three-color immunofluorescence cytometry was used to quantify the expression of different adhesion molecules on CD34+ cells of steady-state bone marrow (BM) and peripheral blood stem cells (PBSC) after mobilizing with G-CSF (10 µg/kg/body weight) in nine cancer patients undergoing high-dose chemotherapy with subsequent autologous blood stem cell rescue. The expression rate of each adhesion molecule on CD34+ cells showed great inter-individual variations. High expression (>50%) on CD34+ cells from PBSC and BM was found for CD58 (leukocyte function-associated antigen-3), CD31 (platelet-endothelial cell adhesion molecule-1), CD11a (leukocyte function-associated antigen-1) and CD49d (very late activation antigen-4); a moderate expression (20%-40%) was seen for CD49e (very late activation antigen-5), CD62L (leukocyte-endothelial cell adhesion molecule), CD54 (ICAM-1) and CD117 (c-kit).

c-kit, CD58, CD62L and CD49d were less expressed on CD34+ cells of PBSC than of BM, the difference being statistically significant for CD49d (p < 0.05). CD49e and CD37 were expressed more in PBSC than BM without being statistically significant. The mean fluorescence intensity for all adhesion molecules on CD34+ cells did not differ significantly between PBSC and BM. The significantly lower expression of CD49d on G-CSF-mobilized PBSCs might suggest that downregulation of this molecule may be involved in the process of peripheral stem cell mobilization.




This article has been cited by other articles:


Home page
Stem CellsHome page
S. Nomura, N. Inami, S. Kanazawa, T. Iwasaka, and S. Fukuhara
Elevation of Platelet Activation Markers and Chemokines during Peripheral Blood Stem Cell Harvest with G-CSF
Stem Cells, September 1, 2004; 22(5): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Y. Gazitt, P. Shaughnessy, and Q. Liu
Expression of Adhesion Molecules on CD34+ Cells in Peripheral Blood of Non-Hodgkin's Lymphoma Patients Mobilized with Different Growth Factors
Stem Cells, February 1, 2001; 19(2): 134 - 143.
[Abstract] [Full Text]


Home page
Stem CellsHome page
Y. Gazitt
Immunologic Profiles of Effector Cells and Peripheral Blood Stem Cells Mobilized with Different Hematopoietic Growth Factors
Stem Cells, November 1, 2000; 18(6): 390 - 398.
[Abstract] [Full Text]


Home page
Stem CellsHome page
S. Lee, S.-A. Im, E.-S. Yoo, E.-M. Nam, M.-A. Lee, J.-Y. Ahn, J.-W. Huh, D.-Y. Kim, S.-N. Lee, M.-J. Kim, et al.
Mobilization Kinetics of CD34+ Cells in Association with Modulation of CD44 and CD31 Expression during Continuous Intravenous Administration of G-CSF in Normal Donors
Stem Cells, July 1, 2000; 18(4): 281 - 286.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1998 by AlphaMed Press.